Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - TripCo Outstanding Awards (Details)

v3.20.4
Stock-Based Compensation - TripCo Outstanding Awards (Details) - 2019 Plan - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Additional disclosures      
Unvested value not yet recognized $ 8,600    
Weighted average period the unrecognized compensation cost will be recognized 2 years    
Series A and B      
Additional disclosures      
Amount of share reserve 3,500    
Stock Options      
Additional disclosures      
Stock options exercised intrinsic value $ 0 $ 0 $ 117
Stock Options | Series A      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding beginning balance 717    
Granted 647    
Forfeited/Cancelled (278)    
Outstanding ending balance 1,086 717  
Options exercisable 367    
WAEP      
Weighted average exercise price, options outstanding (in dollars per share) $ 13.65    
Weighted average exercise price, options granted (in dollars per share) 4.12    
Weighted average exercise price, options forfeited/cancelled (in dollars per share) 14.42    
Weighted average exercise price, options outstanding (in dollars per share) 7.78 $ 13.65  
Weighted average exercise price, options exercisable (in dollars per share) $ 14.37    
Weighted average remaining contractual term outstanding 5 years 9 months 18 days    
Weighted average remaining contractual term exercisable 4 years    
Stock Options | Series B      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding beginning balance 1,824    
Granted 573    
Outstanding ending balance 2,397 1,824  
Options exercisable 2,397    
WAEP      
Weighted average exercise price, options outstanding (in dollars per share) $ 27.63    
Weighted average exercise price, options granted (in dollars per share) 3.76    
Weighted average exercise price, options outstanding (in dollars per share) 21.93 $ 27.63  
Weighted average exercise price, options exercisable (in dollars per share) $ 21.93    
Weighted average remaining contractual term outstanding 4 years 8 months 12 days    
Weighted average remaining contractual term exercisable 4 years 8 months 12 days    
Outstanding, aggregate intrinsic value $ 18,000    
Exercisable, aggregate intrinsic value $ 18,000    
Stock Options | Series B | CEO      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted 573 27  
Restricted Stock and Restricted Stock Units      
Additional disclosures      
Aggregate fair value $ 554 $ 159 $ 9
Restricted Stock and Restricted Stock Units | Series A and B      
Additional disclosures      
Unvested RSUs and MSUs (in shares) 1,800    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 4.64